Scientific Publications

Conrex Pharmaceutical utilizes scientific books and publications to disseminate research findings and increase understanding of its patented technologies.

Scientific Books

1Hsieh, Dean (editor)
Controlled Release Systems: Fabrication Technology, Vol 1 & 2. CRC Press, 1988.
2Hsieh, Dean (editor)
Drug Permeation Enhancement Theory and Applications. Vol. 62. Informa Health Care, 1994.

Pharmaceutical/Medical Products containing PET™

1Schrader S, Mills A, Scheperle M, Block JE. Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males. Clin Cornerstone. 2005;7 Suppl 4:S26-31.
PMID: 16651205 [PubMed – indexed for MEDLINE]

2Steidle C, Witt MA, Matrisciano J, Block JE. Sexual functioning and satisfaction in nonresponders to testosterone gel: Potential effectiveness of retreatment in hypogonadal males.
Clin Cornerstone. 2005;7 Suppl 4:S20-5.
PMID: 16651204 [PubMed – indexed for MEDLINE]

3McNicholas T, Ong T. Review of Testim gel.
Expert Opin Pharmacother. 2006 Mar;7(4):477-84.
PMID: 16503819 [PubMed – in process]

4Bouloux P. Testim 1% testosterone gel for the treatment of male hypogonadism.
Clin Ther. 2005 Mar;27(3):286-98. Review.
PMID: 15878382 [PubMed – indexed for MEDLINE]

5McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA.
A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
BJU Int. 2003 Jan;91(1):69-74.
PMID: 12614254 [PubMed – indexed for MEDLINE]

6Marbury T, Hamill E, Bachand R, Sebree T, Smith T.
Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
Biopharm Drug Dispos. 2003 Apr;24(3):115-20.
PMID: 12673669 [PubMed – indexed for MEDLINE]

Intranasal Insulin (Phase II/III clinical development by Bentley Pharmaceuticals)

1Leary A, Stote R, Breedt H.J., O’brien J, Buckley B
Diabetes Technology & Therapeutics Pharmacokinetics and Pharmacodynamics of Intranasal Insulin Administered to Healthy Subjects in Escalating Doses
Diabetes Technology & Therapeutics. Feb 2005, Vol. 7, No. 1: 124-130

2Leary A, Stote R, Cussen K, O’brien J, Leary W, Buckley B
Diabetes Technology & Therapeutics Pharmacokinetics and Pharmacodynamics of Intranasal Insulin Administered to Patients with Type 1 Diabetes: A Preliminary Study
Diabetes Technology & Therapeutics. Feb 2006, Vol. 8, No. 1: 81-88